Recombinant SLAMF7 (Azintuxizumab Biosimilar) antibody
This Humanized Chimeric antibody specifically detects SLAMF7 (Azintuxizumab Biosimilar) . It exhibits reactivity toward Human.
Catalog No. ABIN7597530
$357.68
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant SLAMF7 (Azintuxizumab Biosimilar) antibody (ABIN7597530)
Target
SLAMF7 (Azintuxizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Conjugate
This SLAMF7 (Azintuxizumab Biosimilar) antibody is un-conjugated
Application
Please inquire
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Azintuxizumab Biosimilar Antibody
-
Specificity
- SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- SLAMF7 (Azintuxizumab Biosimilar)
-
Alternative Name
- Azintuxizumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
-
UniProt
- Q9NQ25
-
CAS-No
- 1826819-57-1
Target
-
You are here:
